ZEB2 and prostate carcinoma: To investigate this, we analysed the correlation between key transcription factors in the EMT pathway—ZEB1, ZEB2, TWIST and SNAI1—and RBM6 using prostate cancer data from the cBioPortal database (Prostate Adenocarcinoma, TCGA, Cell 2015, https://www.cbioportal.org/).